Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the ...

Scientists learned to treat deadly diseases by using viruses to deliver cutting-edge genetic therapies.

Americans have the right to make their own health care choices, including making their own decisions regarding vaccines and whatever purported disease or illness-prevention measures they wish to ...

Adaptive Biotechnologies ( ($ADPT) ) has issued an announcement. On December 30, 2025, Adaptive Biotechnologies announced that its 70%-owned ...

You might know them as the “powerhouses of the cell,” but that’s selling mitochondria short—these microscopic MVPs play a ...

The global immunotherapy drugs market is expected to grow from $260.7 billion in 2025 and is projected to reach $467.4 billion by the end of 2030, at a compound annual growth rate (CAGR) of 12.4% ...

The government must exercise caution in its policy choices, ensuring that short-term growth ambition does not undermine ...

As people live longer, the gut quietly accumulates damage that can tip the balance between healthy tissue renewal and chronic ...

Bread on the Hearses. A child does not need political vocabulary to register that fate can be built as infrastructure: the ...

An immunologist imagines the body’s defense system as a team of unique, quirky characters, showcasing their essential roles.

Claims are spreading on social media that saunas and cold baths can boost immunity, burn fat, and even alleviate joint pain ...

TAMPA, Fla. and LONDON, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology ...